Allergy/Imm Medical News about Asthma Formoterol

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Novel therapies for children with severe asthma

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events
Cochrane Reviews, 10/20/09

Cates CJ et al. – This review sought information from trials that compared the two treatments head–to–head. All subjects were prescribed regular background treatment with inhaled corticosteroids. Three trials on 1116 adults and one trial on 156 children were found. There is not enough information to draw any conclusions on the relative safety of regular formoterol and regular salmeterol in chronic asthma, but serious asthma–related events were rare, and only one non–asthma–related death was reported.

<< Previous
Study: Intervention raises costs for diabetes

Next >>
Effect of natural seasonal pollen exposure and repeated nasal...

Budesonide/formoterol pressurized metered-dose inhaler: a guide to its use in asthma
Drugs & Therapy Perspectives, 10/16/09 Relevance Score: 69%

Budesonide/formoterol effects on metalloproteolytic balance in TGF-beta-activated human lung fibroblasts
Respiratory Medicine, 10/13/09 Relevance Score: 67%

Budesonide/formoterol maintenance and reliever therapy versus conventional best practice
Respiratory Medicine, 10/13/09 Relevance Score: 67%

Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study
Journal of Allergy and Clinical Immunology, 10/09/09 Relevance Score: 48%

Clinical importance of identifying immunoglobulin E-mediated disease in patients with Asthma
Clinical Cornerstone, 10/01/09 Relevance Score: 48%